Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial

Posted on by Alexis
David W Oslin, Kevin G Lynch, Mei-Chiung Shih, Erin P Ingram, Laura O Wray, Sara R Chapman, Henry R Kranzler, Joel Gelernter, Jeffrey M Pyne, Annjanette Stone, Scott L DuVall, Lisa Soleymani Lehmann, Michael E Thase, PRIME Care Research Group; Muhammad Aslam, Steven L Batki, James M Bjork, Frederic C Blow, Lisa A Brenner, Peijun Chen, Shivan Desai, Eric W Dieperink, Scott C Fears, Matthew A Fuller, Courtney S Goodman, David P Graham, Gretchen L Haas, Mark B Hamner, Amy W Helstrom, Robin A Hurley, Michael S Icardi, George J Jurjus, Amy M Kilbourne, Julie Kreyenbuhl, Daniel J Lache, Steven P Lieske, Julie A Lynch, Laurence J Meyer, Cristina Montalvo, Sumitra Muralidhar, Michael J Ostacher, Gayla Y Paschall, Paul N Pfeiffer, Susana Prieto, Ronald M Przygodzki, Mohini Ranganathan, Mercedes M Rodriguez-Suarez, Hannah Roggenkamp, Steven A Schichman, John S Schneeweis, Joseph A Simonetti, Stuart R Steinhauer, Trisha Suppes, Maria A Umbert, Jason L Vassy, Deepak Voora, Ilse R Wiechers, Amanda E Wood